Shantanu Nundy, Chief Medical Officer of Humana Inc., filed a Statement of Changes in Beneficial Ownership on September 3, 2026, disclosing the acquisition of 2,549 restricted stock units of Humana common stock on September 1, 2026.
Key Highlights
- Reporting person: Shantanu Nundy, Chief Medical Officer of Humana Inc.
- Transaction date: September 1, 2026, with the filing signed September 3, 2026.
- Securities acquired: 2,549 restricted stock units of Humana common stock, coded as an acquisition (A).
- Price paid: $0, as disclosed in the filing.
- Resulting ownership: 2,549 shares beneficially owned directly following the reported transaction.
- Plan basis: The units were granted under the Company's 2026 Stock Incentive Plan, exempt under Rule 16b-3(d)(1) and (3).
Humana CMO Acquires RSUs Under 2026 Stock Incentive Plan
According to the filing, Shantanu Nundy, who serves as Chief Medical Officer at Humana Inc. (NYSE:HUM), acquired 2,549 restricted stock units on September 1, 2026. The transaction was recorded with a price of $0, and the filing indicates that each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock. The acquisition is reported as a direct ownership position.
The filing notes that the grant is "exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan." Humana Inc. is a health and well-being company headquartered at 101 E. Main Street, Louisville, Kentucky 40202. The grant was filed individually, with Nundy as the sole reporting person. Following the reported transaction, Nundy's total beneficial ownership stands at 2,549 shares, all held directly, with no derivative securities reported in Table II of the filing.
What Was Disclosed
The filing discloses that Humana's Chief Medical Officer received 2,549 restricted stock units of Humana common stock on September 1, 2026, at no cost, under the company's 2026 Stock Incentive Plan, resulting in direct beneficial ownership of 2,549 shares.



Please wait processing your request...